# DOCIVYX

NDC: 83831-101
Generic name: docetaxel
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240509

FDA application: NDA215813

## Active ingredients

- DOCETAXEL: 20 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4763744e-360e-4d37-be05-cce4114548cd